연구동향 분석

Original Article : Efficacy and Safety of Tenofovir-Based Rescue Therapy for Chronic Hepatitis B Patients with Previous Nucleo(s/t)ide Treatment Failure

( Cho I Lee ) ( So Young Kwon ) ( Jeong Han Kim ) ( Won Hyeok Choe ) ( Chang Hong Lee ) ( Eileen L Yoon ) ( Jong Eun Yeon ) ( Kwan Soo Byun ) ( Yun Soo Kim ) ( Ju Hyun Kim ) 2014년

논문상세정보
인용/피인용
' Original Article : Efficacy and Safety of Tenofovir-Based Rescue Therapy for Chronic Hepatitis B Patients with Previous Nucleo(s/t)ide Treatment Failure' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 기초의학
  • antiviral agents
  • hepatitis b
  • resistance
  • tenofovir
  • treatment outcome
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,383 0

0.0%

' Original Article : Efficacy and Safety of Tenofovir-Based Rescue Therapy for Chronic Hepatitis B Patients with Previous Nucleo(s/t)ide Treatment Failure' 의 참고문헌

  • Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice
    Hongthanakorn C Hepatology 53 : 1854 ~ 1863 - [2011]
  • Virologic response and resistance to adefovir in patients with chronic hepatitis B
    Fung SK J Hepatol 44 : 283 ~ 290 - [2006]
  • Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B
    Heathcote EJ Gastroenterology 140 : 132 ~ 143 - [2011]
  • The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen-positive and hepatitis B e antigen-negative hepatitis B virus strains
    Amini-Bavil-Olyaee S Hepatology 49 : 1158 ~ 1165 - [2009]
  • Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence
    Hall AM Am J Kidney Dis 57 : 773 ~ 780 - [2011]
  • Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations
    Tan J J Hepatol 48 : 391 ~ 398 - [2008]
  • Tenofovir is effective alone or with emtricitabine in adefovir-treated patients with chronic-hepatitis B virus infection
    Berg T Gastroenterology 139 : 1207 ~ 1217 - [2010]
  • Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy
    n Bommel F Hepatology 44 : 318 ~ 325 [2006]
  • Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B
    Marcellin P N Engl J Med 359 : 2442 ~ 2455 - [2008]
  • Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B
    Patterson SJ Gut 60 : 247 ~ 254 - [2011]
  • Response to tenofovir monotherapy in chronic hepatitis B patients with prior suboptimal response to entecavir
    Pan CQ J Viral Hepat 19 : 213 ~ 219 - [2012]
  • Rescue therapy for lamivudine-resistant chronic hepatitis B: comparison between entecavir 1.0 mg monotherapy, adefovir monotherapy and adefovir add-on lamivudine combination therapy
    Kim HJ J Gastroenterol Hepatol 25 : 1374 ~ 1380 - [2010]
  • Long-term safety of lamivudine treatment in patients with chronic hepatitis B
    Lok AS Gastroenterology 125 : 1714 ~ 1722 - [2003]
  • Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
    Marcellin P Hepatology 48 : 750 ~ 758 - [2008]
  • Lamivudine, adefovir and tenofovir exhibit long-lasting anti-hepatitis B virus activity in cell culture
    Ying C J Viral Hepat 7 : 79 ~ 83 - [2000]
  • Lamivudine for patients with chronic hepatitis B and advanced liver disease
    Liaw YF N Engl J Med 351 : 1521 ~ 1531 - [2004]
  • Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virus
    Delaney WE 4th Antimicrob Agents Chemother 50 : 2471 ~ 2477 [2006]
  • Inhibition of the replication of the DNA polymerase M550V mutation variant of human hepatitis B virus by adefovir, tenofovir, L-FMAU, DAPD, penciclovir and lobucavir
    Ying C J Viral Hepat 7 : 161 ~ 165 - [2000]
  • Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy
    Lee YS Hepatology 43 : 1385 ~ 1391 - [2006]
  • In vitro susceptibility of adefovir-associated hepatitis B virus polymerase mutations to other antiviral agents
    Qi X Antivir Ther 12 : 355 ~ 362 - [2007]
  • Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study
    Petersen J J Hepatol 56 : 520 ~ 526 - [2012]
  • EASL clinical practice guidelines: management of chronic hepatitis B
    European Association for the Study of the Liver J Hepatol 50 : 227 ~ 242 [2009]
  • Drug resistance in antiviral treatment for infections with hepatitis B and C viruses
    Yotsuyanagi H J Gastroenterol 42 : 329 ~ 335 - [2007]
  • Chronic hepatitis B
    Lok AS Hepatology 45 : 507 ~ 539 - [2007]
  • Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
    Marcellin P N Engl J Med 348 : 808 ~ 816 - [2003]